Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Ephrin type-A receptor 3 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Myelodysplastic Syndromes | 1 | D009190 | ClinicalTrials |
| Glioblastoma | 1 | D005909 | ClinicalTrials |
| Primary Myelofibrosis | 1 | D055728 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109398 |
CONTENTS